Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Expression patterns of endothelial permeability pathways in the development of the blood-retinal barrier in mice.

van der Wijk AE, Wisniewska-Kruk J, Vogels IMC, van Veen HA, Ip WF, van der Wel NN, van Noorden CJF, Schlingemann RO, Klaassen I.

FASEB J. 2019 Jan 30:fj201801499RRR. doi: 10.1096/fj.201801499RRR. [Epub ahead of print]

2.
3.

Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.

van der Wijk AE, Canning P, van Heijningen RP, Vogels IMC, van Noorden CJF, Klaassen I, Schlingemann RO.

Acta Ophthalmol. 2019 Mar;97(2):214-224. doi: 10.1111/aos.13909. Epub 2018 Aug 31.

PMID:
30168271
4.

IGF2 and IGF1R identified as novel tip cell genes in primary microvascular endothelial cell monolayers.

Dallinga MG, Yetkin-Arik B, Kayser RP, Vogels IMC, Nowak-Sliwinska P, Griffioen AW, van Noorden CJF, Klaassen I, Schlingemann RO.

Angiogenesis. 2018 Nov;21(4):823-836. doi: 10.1007/s10456-018-9627-4. Epub 2018 Jun 27.

5.

Spatial and temporal recruitment of the neurovascular unit during development of the mouse blood-retinal barrier.

van der Wijk AE, Vogels IMC, van Veen HA, van Noorden CJF, Schlingemann RO, Klaassen I.

Tissue Cell. 2018 Jun;52:42-50. doi: 10.1016/j.tice.2018.03.010. Epub 2018 Mar 23.

6.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW.

Angiogenesis. 2018 Aug;21(3):425-532. doi: 10.1007/s10456-018-9613-x. Review.

7.

Involvement of the ubiquitin-proteasome system in the expression of extracellular matrix genes in retinal pigment epithelial cells.

Ramos de Carvalho JE, Verwoert MT, Vogels IMC, Reits EA, Van Noorden CJF, Klaassen I, Schlingemann RO.

Biochem Biophys Rep. 2018 Jan 28;13:83-92. doi: 10.1016/j.bbrep.2018.01.005. eCollection 2018 Mar.

8.

Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes.

Klaassen I, de Vries EW, Vogels IMC, van Kampen AHC, Bosscha MI, Steel DHW, Van Noorden CJF, Lesnik-Oberstein SY, Schlingemann RO.

PLoS One. 2017 Nov 2;12(11):e0187304. doi: 10.1371/journal.pone.0187304. eCollection 2017.

9.

Modulation of the Proteasome Pathway by Nano-Curcumin and Curcumin in Retinal Pigment Epithelial Cells.

Ramos de Carvalho JE, Verwoert MT, Vogels IMC, Schipper-Krom S, Van Noorden CJF, Reits EA, Klaassen I, Schlingemann RO.

Ophthalmic Res. 2018;59(2):98-109. doi: 10.1159/000481261. Epub 2017 Oct 27.

PMID:
29073609
10.

Development of Refractive Errors-What Can We Learn From Inherited Retinal Dystrophies?

Hendriks M, Verhoeven VJM, Buitendijk GHS, Polling JR, Meester-Smoor MA, Hofman A; RD5000 Consortium, Kamermans M, Ingeborgh van den Born L, Klaver CCW.

Am J Ophthalmol. 2017 Oct;182:81-89. doi: 10.1016/j.ajo.2017.07.008. Epub 2017 Jul 25.

PMID:
28751151
11.

Is leukostasis a crucial step or epiphenomenon in the pathogenesis of diabetic retinopathy?

van der Wijk AE, Hughes JM, Klaassen I, Van Noorden CJF, Schlingemann RO.

J Leukoc Biol. 2017 Oct;102(4):993-1001. doi: 10.1189/jlb.3RU0417-139. Epub 2017 Jul 19. Review.

PMID:
28724696
12.

TNFα-Induced Disruption of the Blood-Retinal Barrier In Vitro Is Regulated by Intracellular 3',5'-Cyclic Adenosine Monophosphate Levels.

van der Wijk AE, Vogels IMC, van Noorden CJF, Klaassen I, Schlingemann RO.

Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3496-3505. doi: 10.1167/iovs.16-21091.

PMID:
28715583
13.

Correction: CD34 Promotes Pathological Epi-Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy.

Siemerink MJ, Hughes MR, Dallinga MG, Gora T, Cait J, Vogels IM, Yetkin-Arik B, Van Noorden CJ, Klaassen I, McNagny KM, Schlingemann RO.

PLoS One. 2016 Dec 21;11(12):e0169061. doi: 10.1371/journal.pone.0169061. eCollection 2016.

14.

Association of Circulating Markers With Outcome Parameters in the Bevacizumab and Ranibizumab in Diabetic Macular Edema Trial.

Fickweiler W, Klaassen I, Vogels IM, Hooymans JM, Wolffenbuttel BH, Los LI, Schlingemann RO; BRDME Research Group.

Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6234-6241. doi: 10.1167/iovs.16-20157.

PMID:
27842163
15.

Computational Screening of Tip and Stalk Cell Behavior Proposes a Role for Apelin Signaling in Sprout Progression.

Palm MM, Dallinga MG, van Dijk E, Klaassen I, Schlingemann RO, Merks RM.

PLoS One. 2016 Nov 9;11(11):e0159478. doi: 10.1371/journal.pone.0159478. eCollection 2016.

16.

CD34 Promotes Pathological Epi-Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy.

Siemerink MJ, Hughes MR, Dallinga MG, Gora T, Cait J, Vogels IM, Yetin-Arik B, Van Noorden CJ, Klaassen I, McNagny KM, Schlingemann RO.

PLoS One. 2016 Jun 28;11(6):e0157902. doi: 10.1371/journal.pone.0157902. eCollection 2016. Erratum in: PLoS One. 2016 Dec 21;11(12 ):e0169061.

17.

Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.

Wisniewska-Kruk J, van der Wijk AE, van Veen HA, Gorgels TG, Vogels IM, Versteeg D, Van Noorden CJ, Schlingemann RO, Klaassen I.

Am J Pathol. 2016 Apr;186(4):1044-54. doi: 10.1016/j.ajpath.2015.11.019. Epub 2016 Feb 12.

PMID:
26878208
18.

The role of CTGF in diabetic retinopathy.

Klaassen I, van Geest RJ, Kuiper EJ, van Noorden CJ, Schlingemann RO.

Exp Eye Res. 2015 Apr;133:37-48. doi: 10.1016/j.exer.2014.10.016. Review.

PMID:
25819453
19.

Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.

Wisniewska-Kruk J, Klaassen I, Vogels IM, Magno AL, Lai CM, Van Noorden CJ, Schlingemann RO, Rakoczy EP.

Exp Eye Res. 2014 May;122:123-31. doi: 10.1016/j.exer.2014.03.005. Epub 2014 Apr 3.

PMID:
24703908
20.

Connective tissue growth factor is involved in structural retinal vascular changes in long-term experimental diabetes.

Van Geest RJ, Leeuwis JW, Dendooven A, Pfister F, Bosch K, Hoeben KA, Vogels IM, Van der Giezen DM, Dietrich N, Hammes HP, Goldschmeding R, Klaassen I, Van Noorden CJ, Schlingemann RO.

J Histochem Cytochem. 2014 Feb;62(2):109-18. doi: 10.1369/0022155413512656. Epub 2013 Nov 11.

Supplemental Content

Loading ...
Support Center